You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Folate receptor α (FOLR1)

Showing 1 - 25 of 9,239
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial (Luveltamab tazevibulin, Pegfilgrastim)

Not yet recruiting
  • Ovarian Cancer
  • +4 more
  • (no location specified)
May 12, 2023

Endometrial Cancer Trial in New Haven (IMGN853)

Recruiting
  • Endometrial Cancer
  • New Haven, Connecticut
    Smilow Cancer Hospital at Yale New Haven
Aug 10, 2022

Epithelial Ovarian Cancer, NSCLC, Renal Cell Carcinoma Trial in Saint Louis, New York (ITIL-306)

Recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • ITIL-306
  • Saint Louis, Missouri
  • +1 more
Aug 15, 2022

Ovarian Cancer, Fallopian Tube, Primary Peritoneal Cancer Trial in Birmingham (mirvetuximab soravtansine (MIRV; IMGN853))

Recruiting
  • Ovarian Cancer
  • +2 more
  • mirvetuximab soravtansine (MIRV; IMGN853)
  • Birmingham, Alabama
    University of Alabama at Birmingham Womens & Infants Center
Jun 30, 2022

Fanconi Anemia, Severe Aplastic Anemia, MDS Trial in Minneapolis (Total Body Irradiation (TBI) (Plan 1), Cyclophosphamide (CY)

Recruiting
  • Fanconi Anemia
  • +2 more
  • Total Body Irradiation (TBI) (Plan 1)
  • +8 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 2, 2022

Neuroendocrine Tumor Grade 2, Neuroendocrine Tumor Grade 1 Trial ([203Pb]VMT-a-NET, SPECT/CT)

Enrolling by invitation
  • Neuroendocrine Tumor Grade 2
  • Neuroendocrine Tumor Grade 1
  • Iowa City, Iowa
    The University of Iowa
Dec 9, 2022

Bilateral Breast Carcinoma, Breast Inflammatory Carcinoma, Stage IB Breast Cancer AJCC v7 Trial in United States (drug, other,

Active, not recruiting
  • Bilateral Breast Carcinoma
  • +11 more
  • Scottsdale, Arizona
  • +11 more
Jan 12, 2023

Advanced Solid Tumors Trial in Changchun (BAT8006 for Injection)

Recruiting
  • Advanced Solid Tumors
  • BAT8006 for Injection
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Jul 26, 2022

Ovarian Cancer, Ovarian Carcinoma, Ovary Cancer Trial in United States (STRO-002, Bevacizumab)

Recruiting
  • Ovarian Cancer
  • +4 more
  • Tampa, Florida
  • +5 more
Aug 1, 2022

ER+ Breast Cancer Trial in Sherbrooke (4FMFES-PET)

Recruiting
  • ER+ Breast Cancer
  • 4FMFES-PET
  • Sherbrooke, Quebec, Canada
    Université deSherbrooke
Jul 18, 2022

Advanced Solid Tumor, Advanced Cancer, Advanced Carcinoma Trial (AMT-151)

Not yet recruiting
  • Advanced Solid Tumor
  • +18 more
  • (no location specified)
Aug 10, 2022

Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in China (Mirvetuximab Soravtansine)

Recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • Mirvetuximab Soravtansine
  • Bengbu, Anhui, China
  • +27 more
Nov 14, 2022

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma Trial in Boston,

Active, not recruiting
  • Estrogen Receptor-positive Breast Cancer
  • +5 more
  • PI3K inhibitor BYL719
  • +3 more
  • Boston, Massachusetts
  • +1 more
Oct 14, 2022

Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab Soravtansine)

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • Mirvetuximab Soravtansine
  • Phoenix, Arizona
  • +88 more
Jan 19, 2023

Ovarian Cancer Trial in United States (TPIV200, Durvalumab)

Completed
Has Results
  • Ovarian Cancer
  • TPIV200
  • Durvalumab
  • Basking Ridge, New Jersey
  • +4 more
Nov 1, 2021

Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab Soravtansine, Paclitaxel,

Active, not recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • Mirvetuximab Soravtansine
  • +3 more
  • Birmingham, Alabama
  • +207 more
Oct 28, 2022

Ovary Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Aurora (Mirvetuximab Soravtansine, Olaparib)

Not yet recruiting
  • Ovary Cancer
  • +2 more
  • Aurora, Colorado
    University of Colorado Hospital
May 30, 2023

Tumors Trial in Canada, United States (Mirvetuximab soravtansine)

Completed
Has Results
  • Tumors
  • Mirvetuximab soravtansine
  • Fairway, Kansas
  • +11 more
Jan 27, 2021

Solid Tumor Trial in United Kingdom, United States (Farletuzumab ecteribulin)

Recruiting
  • Solid Tumor
  • Farletuzumab ecteribulin
  • Tucson, Arizona
  • +26 more
Jan 30, 2023

Human Cancers Trial in Cambridge, London (MOv18 IgE)

Completed
  • Human Cancers
  • MOv18 IgE
  • Cambridge, United Kingdom
  • +2 more
May 19, 2022

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)

Active, not recruiting
  • BRCA1 Gene Mutation
  • +9 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine plus Bevacizumab, Bevacizumab)

Recruiting
  • Ovarian Cancer
  • +2 more
  • New Orleans, Louisiana
  • +3 more
Dec 16, 2022

Epithelial Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab soravtansine,

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • Mirvetuximab soravtansine
  • +4 more
  • Birmingham, Alabama
  • +15 more
Dec 13, 2021

Ovarian Cancer, Ovarian Carcinoma, Ovary Cancer Trial in Spain, United States (STRO-002)

Recruiting
  • Ovarian Cancer
  • +6 more
  • Tucson, Arizona
  • +25 more
Dec 20, 2021

Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab soravtansine)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Mirvetuximab soravtansine
  • Anchorage, Alaska
  • +55 more
Jul 25, 2022